Clinical and Radiologic Evaluation of an Individual with Hypochondroplasia and a Novel FGFR3 Mutation

Abstract

Hypochondroplasia (HCH), a skeletal dysplasia caused by mutations in the fibroblast growth factor receptor 3 (FGFR3) gene, is characterized by disproportionate short stature. The p.Asn540Lys (p.N540K) mutation accounts for ∼50 to 70% of cases of HCH, but novel FGFR3 mutations are described. We present a family with disproportionately short stature and mild radiologic findings seen in a major public pediatric hospital in Argentina. A previously undescribed heterozygous missense variant in FGFR3, NM_000142.4:667C > T; p.(Arg223Cys) was identified. The predicted phenotype correlates well with the mild auxologic and radiologic characteristics observed. In this case, disproportionately short stature raised the suspicion of skeletal dysplasia.

Keywords

hypochondroplasia - body disproportion - FGFR3

• References

• 1 Spranger JW, Brill PW, Nishimura G, Superti-Furga A, Unger S. Hypochondroplasia. In: Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development, 3rd ed. New York, NY: Oxford University Press; 2012: 11-14
• 2 Bonafe L, Cormier-Daire V, Hall C. , et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet A 2015; 167A (12) 2869-2892
• 3 Bellus GA, McIntosh I, Smith EA. , et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet 1995; 10 (03) 357-359
• 4 Arenas MA, Del Pino M, Fano V. FGFR3-related hypochondroplasia: longitudinal growth in 57 children with the p.Asn540Lys mutation. J Pediatr Endocrinol Metab 2018; 31 (11) 1279-1284
• 5 Fano V, Gravina LP, Pino MD, Chertkoff L, Barreiro C, Lejarraga H. High specificity of head circumference to recognize N540K mutation in hypochondroplasia. Ann Hum Biol 2005; 32 (06) 782-788
• 6 Hall BD, Spranger J. Hypochondroplasia: clinical and radiological aspects in 39 cases. Radiology 1979; 133 (01) 95-100
• 7 Saito T, Nagasaki K, Nishimura G. , et al. Criteria for radiologic diagnosis of hypochondroplasia in neonates. Pediatr Radiol 2016; 46 (04) 513-518
• 8 Rousseau F, Bonaventure J, Legeai-Mallet L. , et al. Clinical and genetic heterogeneity of hypochondroplasia. J Med Genet 1996; 33 (09) 749-752
• 9 Xue Y, Sun A, Mekikian PB. , et al. FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry. Mol Genet Genomic Med 2014; 2 (06) 497-503
• 10 Grigelioniené G, Hagenäs L, Eklöf O, Neumeyer L, Haereid PE, Anvret M. A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online. Hum Mutat 1998; 11 (04) 333
• 11 Bellus GA, Spector EB, Speiser PW. , et al. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. Am J Hum Genet 2000; 67 (06) 1411-1421
• 12 Mortier G, Nuytinck L, Craen M, Renard JP, Leroy JG, de Paepe A. Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene. J Med Genet 2000; 37 (03) 220-224
• 13 Winterpacht A, Hilbert K, Stelzer C. , et al. A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia. Physiol Genomics 2000; 2 (01) 9-12
• 14 Heuertz S, Le Merrer M, Zabel B. , et al. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. Eur J Hum Genet 2006; 14 (12) 1240-1247
• 15 Nagahara K, Harada Y, Futami T, Takagi M, Nishimura G, Hasegawa Y. A Japanese familial case of hypochondroplasia with a novel mutation in FGFR3. Clin Pediatr Endocrinol 2016; 25 (03) 103-106
• 16 Couser NL, Pande CK, Turcott CM, Spector EB, Aylsworth AS, Powell CM. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation. Am J Med Genet A 2017; 173 (04) 1097-1101
• 17 Chen J, Yang J, Zhao S, Ying H, Li G, Xu C. Identification of a novel mutation in the FGFR3 gene in a Chinese family with Hypochondroplasia. Gene 2018; 641: 355-360
• 18 Comité Nacional de Crecimiento y Desarrollo. Guía para la evaluación del crecimiento físico, 3era edición. Argentina: Sociedad Argentina de Pediatría; 2013
• 19 Del Pino M, Orden AB, Arenas MA, Fano V. Argentine references for the assessment of body proportions from birth to 17 years of age [in Spanish]. Arch Argent Pediatr 2017; 115 (03) 234-240
• 20 Barraza-García J, Rivera-Pedroza CI, Hisado-Oliva A. , et al. Broadening the phenotypic spectrum of POP1-skeletal dysplasias: identification of POP1 mutations in a mild and severe skeletal dysplasia. Clin Genet 2017; 92 (01) 91-98
• 21 Richards S, Aziz N, Bale S. , et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 22 del Pino M, Aza-Carmona M, Medino-Martin D. , et al. SHOX deficiency in an Argentinian cohort: long term auxological follow-up and a family's new mutation. J Pediatr Genet 2019; 8 (03) 123-132
• 23 Savarirayan R, Rossiter JP, Hoover-Fong JE. , et al; Skeletal Dysplasia Management Consortium. Best practice guidelines regarding prenatal evaluation and delivery of patients with skeletal dysplasia. Am J Obstet Gynecol 2018; 219 (06) 545-562
• 24 Linnankivi T, Mäkitie O, Valanne L, Toiviainen-Salo S. Neuroimaging and neurological findings in patients with hypochondroplasia and FGFR3 N540K mutation. Am J Med Genet A 2012; 158A (12) 3119-3125
• 25 Okazaki T, Saito Y, Ueda R. , et al. Epileptic phenotype of FGFR3-related bilateral medial temporal lobe dysgenesis. Brain Dev 2017; 39 (01) 67-71
• 26 Romeo A, Lodi M, Viri M. , et al. Does the co-occurrence of FGFR3 gene mutation in hypochondroplasia, medial temporal lobe dysgenesis, and focal epilepsy suggest a syndrome?. Pediatr Neurol 2014; 50 (04) 427-430